KCT0002686招募中未知
Therapeutic Efficacy of Autologous Platelet Concentrate on Macular hole with High myopia, Large Macular Hole or Recurrent Macular Hole ; Randomized clinical trial
ational Evidence-based Healthcare Callaborating Agency0 个研究点目标入组 194 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 194
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 o Limit(—)
- 性别
- All
入选标准
- •Patients who were diagnosed as full-thickness macular hole by optical coherence tomography with visual acuity of affected eye under 20/50 were included. All subject had to meet at least one of the following conditions.
- •1) macular hole over 400µmof minimum size
- •2) macular hole at high myopic eye (spherical equivalent over -6.0 diopters, or axial length over 25.5 millimeters)
- •3) relapsed of recurrent macular hole
排除标准
- •Patients with any following condition were excluded.
- •1. Pregnancy
- •2. History of retinal detachment, or proliferative vitreoretinopathy in affected eye
- •3. History of vitreoretinal surgery for the ocular disease other than macular hole
- •4. Proliferative diabetic retinopathy, vitreous hemorrhage, retinal vascular obstruction, uveitis, trauma, optic nerve atrophy, intraocular tumor, or visually significant corneal opacity in affected eye
- •5. Confirmed or suspicious intraocular/periocular infection
- •6. Uncontrolled high Intraocular pressure (over 21 mmHg) with maximal tolerant medical treatment, or history of glaucoma surgery
- •7. Contraindications for using autologous platelet concentrate (thrombocytopenia,any type of thromboasthenia, positive serology of hepatitis B, C, or human immunodeficiency virus, positive serology of syphilis)
- •8. Hemodynamic instability
- •9. Septicemia
- •10. Event of fever, or active infectious disease within two weeks
- •11. Cancer without complete remission, treatment history of cancer or within a year
- •12. Alcoholism or other psychiatric disease which could have a significant effect on this study
- •13. Bleeding tendency by long-term administration of anti-platelet or anti-coagulant agents (the patients who stop the medication for recommended wash-out period could be included)
- •14. Administration of other drugs for clinical trial within 30 days
研究者
相似试验
招募中
3 期
Efficacy of autologous platelet-rich plasma and laser acupuncture in the treatment of non-obstructive azoospermiaAzoospermiaIRCT20111121008146N43Shahid Beheshti University of Medical Sciences30
进行中(未招募)
1 期
Efficacy of plasma injections, and extracorporeal shock wave therapy, in thetreatment of work –related lateral epicondylitisThe epicondylitis is an overuse injury, in most cases, is a self-limited course andresponds well to conservative treatment. Its etiology is degenerative and is relatedto a repetitive overuse and underlying tendinopathy.EUCTR2018-002650-67-ESIbermutuamur (Mutua Colaboradora con la Seguridad Social nº 274)66
进行中(未招募)
1 期
Check the efficacy of PRP in vascular ulcers in primary care.EUCTR2014-001514-26-ESComarca Ezkerraldea-Enkarterri (OSAKIDETZA)150
招募中
不适用
Assessment the effect of using autologous platelet rich plasma (PRP) in prevention of hypertrophic scarHypertrophic scarIRCT20201007048955N2Clinical Research Development Center50
尚未招募
Unknown
Clinical and radiographic comparison of extraction socket healing of mandibular third molars following the use of autologous platelet-rich plasma and fibrin :randomized controlled trial.bony defectOral and Gastrointestinal - Normal oral and gastrointestinal development and functionACTRN12624001146583Ufaq rao ,shifa dental hospital12
